TARRYTOWN, N.Y., March 22, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has extended the approval of Evkeeza® (evinacumab-dgnb) as an adjunct to other lipid-lowering therapies to…
CARLSBAD, Calif., March 7, 2023 /PRNewswire/ — Ionis Pharmaceuticals (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for eplontersen, an investigational antisense medicine…
Unique Community-Based Partnership With the Association of Black Cardiologists and Morehouse School of Medicine to Identify Study Sites and Participants Observational Study to Better Understand Associations Between Lp(a) Levels and Atherosclerotic Cardiovascular…
Michelle A. Albert, MD, MPH, past president of the ABC and current president of the American Heart Association, is featured in several articles in TIME Magazine’s recent end of year…
The DIVERSE Network, a collaboration between Morehouse School of Medicine in Atlanta, GA and Stanford University School of Medicine in Stanford, California, is seeking exceptional candidates to be part of…
If approved, Evkeeza would be the first and only treatment of its kind to help children as young as 5 years old control dangerously high levels of LDL cholesterol caused…
